T2EVOLVE
Accelerating development and improving access to CAR and TCR-engineered T cell therapy
keywords: IMI projects Cancer Biologicals Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Manufacturing technologies
- Project website
- https://t2evolve.com/
- Start date
- 2021-01-01
- End date
- 2025-12-31
- Funding
- IMI2 - Call 18 (Grant number 945393)
- Types
- IMI projects
